CME

Guest: Arlene B. Chapman, MD

Guest: Matthew B. Lanktree, MD, PhD

This Expert Exchange webcast aims to improve clinicians’ ability to detect and diagnose ADPKD in at-risk patients.

Guest: Jimmy T. Lee, MD

Guest: Arlene B. Chapman, MD

This Expert Exchange webcast aims to better define the importance radiological imaging plays in the management of patients with autosomal dominant polycystic kidney disease (ADPKD).

Host: Charles Turck, PharmD, BCPS, BCCCP

Guest: Mira Irons, MD

Guest: Shannon Curtis

Following the approval of the first COVID-19 vaccine, mass-vaccination has made approving a vaccine difficult. How are the Food and Drug Administration and the Centers for Disease Control deciding on which vaccinations to authorize? Dr. Mira Irons and Shannon Curtis of the American Medical Association join Dr. Charles Turck to discuss authorization processes and recommendations for COVID-19 vaccines.

Host: Robert A. Hauser, MD, MBA, FAAN

Guest: Stuart H. Isaacson, MD

Please note: This activity is no longer available for continuing education credit.

This Expert Exchange activity is designed to make clinicians aware of the potential for emerging pharmacotherapies in treating patients with Parkinson’s disease.

You can access the Clinical Compendium for Novel Therapies to Manage OFF Episodes in Patients with Parkinson’s Disease by clicking the link here.

Host: Jennifer Caudle, DO

Guest: Koryn Rubin

With the widespread impacts of the COVID-19 pandemic, the Centers for Medicare and Medicaid Services is now offering flexibility for clinicians participating in the Merit-Based Incentive Payment System, MIPS. But what exactly does that flexibility entail? Dr. Jennifer Caudle is joined by Koryn Rubin to discuss how this impacts healthcare professionals.

Since the original date of this recording, CMS has extended the deadline for its applications related to MIPS hardships from December 31, 2020 to February 1, 2021.

Host: Mikhail Kosiborod, MD

Despite evidence and guideline recommendations, renin-angiotensin-aldosterone system inhibitor (RAASi) therapy tends to be used suboptimally among patients with heart failure (HF), particularly in patients with chronic kidney disease (CKD). What are the real-world factors that influence RAASi treatment decisions in patients with HF who have or are at risk for hyperkalemia? Hear about how the CARE HK in HF study is being designed to explore the real-world data surrounding this question and its associated impact on outcomes.

Guest: David P. Hudesman, MD

Please note: This activity is no longer available for continuing education credit.

It is estimated that only 20% to 30% of patients with Crohn’s disease (CD) have a non-progressive or indolent course. While most patients with CD present with non-penetrating or non-stricturing disease, 50% of patients develop intestinal complications within 20 years of diagnosis. In this interactive CME activity, Dr. Hudesman presents the case of a patient with CD, highlighting the importance of early recognition of disease complications and considerations for surgical management. This real-world patient case offers you an opportunity to test your clinical skills for the successful management of inflammatory bowel disease (IBD) and learn more from an IBD expert faculty.

Guest: Peter A. Lio, MD

Guest: Mark Boguniewicz, MD

Guest: Eric Simpson, MD, MCR

Please note: This activity is no longer available for continuing education credit.

Tune in as a multidisciplinary panel discusses a clinician's question about the appropriateness of combining two biologics in a very young child with several atopic diseases.

Guest: Peter A. Lio, MD

Guest: Mark Boguniewicz, MD

Guest: Eric Simpson, MD, MCR

Please note: This activity is no longer available for continuing education credit.

A multidisiplinary panel is presented with a highly allergic, extremely refractory patient with atopic dermatitis. Her dermatologist wants to take the next step and start her on a biologic, but she's worried about the patient's occular history and dupilumab's conjunctivitis risk. Find out what the experts have to say about this doctor's dilemma.

Guest: Peter A. Lio, MD

Guest: Mark Boguniewicz, MD

Guest: Eric Simpson, MD, MCR

Please note: This activity is no longer available for continuing education credit.

Infants have the highest incidence of atopic dermatitis in the US but the fewest treatment options. This is a case a doctor submitted about a baby who is refractory to multiple oral and topical treatments. A multidisciplinary panel discusses how they would approach the baby's treatment, emerging options for this vulnerable patient population, and if anything can be done now to prevent progression of the atopic march later.